NorthWest Biotherapeutics Inc (NWBO)

[LearningEveryTrade]

What happens to trial when pseudo progression caused patients on SOC to crossover to DCVax-L, when they maybe shouldn't have ??

Has there been any discussion on this part of it?

It seems to be my biggest worry.

It would seem hard to show DCvax worked, because SOC was working too, but now we can't tell which was causing tumor regression/survival. SOC or the SOC/DCVax-L crossover combo.

I also suppose, this is maybe why we need outside data so much.